Serclutamab talirine

Synonyms: ABBV-321, Anti-Egfr/pbd antibody-drug conjugate ABBV-321

Catalog No.D4027 Purity:96.45%

Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.

CAS No. 2140174-56-5

Purity & Quality Control

Batch: D402701 Purity: 96.45% Protein concentration: 4.06mg/ml Endotoxin Level: ＜1EU/mg

96.45

Choose Selective EGFR Inhibitors

Name	Citation	EGFR/ErbB1	HER2/ErbB2	ErbB3	ErbB4	mutant EGFR	Others
Saracatinib (AZD0530)	279	+++					c-Src,LCK,c-YES
Canertinib (CI-1033)	46	++++	+++
AG-490	127	+					JAK2 (V617F)
CP-724714	107		++
WZ4002	34	++++
Sapitinib (AZD8931)	46	+++	+++	+++
CUDC-101	22	+++	++				HDAC,HDAC1,HDAC6
AG-1478	94	+++
PD153035 HCl	16	++++
Pelitinib (EKB-569)	11	+	+				Src,MEK/ERK,Raf
AEE788 (NVP-AEE788)	13	++++	+++		+		c-Abl,FLT1,c-Fms
AC480 (BMS-599626)	10	++	++		+
AP26113-analog (ALK-IN-1)	4					++	ALK,IGF1R,INSR
WZ3146	1	++++
Allitinib tosylate	16	++++	+++		++++
Rociletinib (CO-1686)	36	++
Varlitinib	8	+++	++++
Icotinib (BPI-2009H)	8	+++
TAK-285	4	++	++		+		MEK1,Aurora B,LCK
WHI-P154	11	+++					VEGFR,Src,JAK3
Daphnetin	4	+					PKA,PKC
PD168393	5	++++
CNX-2006	2	++				++
Tyrphostin 9	1	+					PDGFR
AG-18	1	+
4-AMino-1-phenylpyrazolo[3,4-d]pyriMidine	0	+
AST-1306	0	++++	+++		++++
ErbB2 inhibitor	0		+		+
Tuxobertinib (BDTX-189)	2	++++	++++				RIPK2,BLK
Epertinib hydrochloride	0	++++	+++		+++
JND3229	0	+++				++	EGFR C797S
BI-4020	0					++++
Tyrphostin AG-528	0	+	+
AG 556	0	+
Canertinib dihydrochloride	8	+++	+++
EGFR Inhibitor	2	++					Microtubules
SU5214	0	+					VEGFR2
RG 13022	0	+
TQB3804	0					++++
zipalertinib (TAS6417)	3	+++			+++	++++	TXK,BMX
Pyrotinib dimaleate	4	++	++
PD153035	14	++++
AG 494	0	+
AG 555	0	+
Theliatinib (HMPL-309)	0	+++				++
Avitinib (Abivertinib)	2					++++	JAK3,BTK
Lazertinib	5	++++				++++	Del19,L85R
Lifirafenib (BGB-283)	6	++				+	WT A-RAF,C-RAF (Y340/341D),BRAF(V600E)
Nazartinib (EGF816)	6	++				++
Zorifertinib (AZD3759)	6	++++
CL-387785 (EKI-785)	4	++++
Poziotinib	33	+++	+++		++
AZ5104	4	++++			+++		BLK,ACK1,BRK
AV-412 free base	0	++++	++			++++
HER2-Inhibitor-1		✔
WZ8040	✔
Genistein	✔					topo II
BDTX-1535	✔
Falnidamol	✔
BLU-945	✔
Sunvozertinib (DZD9008)	✔
CH7233163	✔
Licochalcone D	✔					PARP,Caspase,Met
Alflutinib (Furmonertinib) mesylate	✔					CYP3A4
(Rac)-JBJ-04-125-02	✔
Tyrphostin AG30 (AG30)	✔
AG-1557	✔
AG99	✔
MTX-211	✔					PI3K
RG14620	✔					ABCG2
Almonertinib (HS-10296)					✔
Cyasterone	✔
Norcantharidin	✔					c-Met
Naquotinib(ASP8273)	✔
EAI045					✔
Olmutinib (BI 1482694)	✔					BTK
Butein	✔
Chrysophanic Acid	✔					mTOR
EGCG ((-)-Epigallocatechin Gallate)		✔				FASN,DNMT,telomerase

Expand to Check More

1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description	Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.

Description

References
[1] Carneiro BA, et al. Journal of Clinical Oncology 38, no. 15_suppl

References

[1] Carneiro BA, et al. Journal of Clinical Oncology 38, no. 15_suppl

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	2140174-56-5
ADC antiody	Serclutamab
ADC cytotoxin	PBD
Formulation	1xPBS
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

* Name Please enter your name.

* Email Please enter your email. Please enter a valid email address.

Phone

* Comments: Please write something to us.